Metadata Search
Actinium Pharmaceuticals
Page 1 of 18 results
Sort by: relevance publication year Download as CSV

Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia

Journal Article published Jun 2016 in Biology of Blood and Marrow Transplantation volume 22 issue 6 on pages 1024 to 1029

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | Leukemia and Lymphoma Society | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases (U24-CA076518) | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U10HL069294) | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | U.S. Department of Health and Human Services (HHSH250201200016C) | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Terumo BCT | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Milliman | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Reinhold Munker, Ruta Brazauskas, Hai Lin Wang, Marcos de Lima, Hanna J. Khoury, Robert Peter Gale, Richard T. Maziarz, Brenda M. Sandmaier, Daniel Weisdorf, Wael Saber

New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell Transplantation

Journal Article published Apr 2016 in Biology of Blood and Marrow Transplantation volume 22 issue 4 on pages 768 to 770

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (HHSH250201200016C) | U.S. Public Health Service (U24-CA076518) | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | Leukemia and Lymphoma Society | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases (5U10HL069294) | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Terumo BCT | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration (N00014-13-1-0039, N00014-14-1-0028) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Institutional Research | Milliman | Office of Naval Research | Chimerix, Inc. | Jeff Gordon Children's Foundation | American Cancer Society (86-004-26) | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Anita D'Souza, Jiaxing Huang, Parameswaran Hari

In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in Children

Journal Article published Dec 2015 in Biology of Blood and Marrow Transplantation volume 21 issue 12 on pages 2173 to 2179

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (U24-CA076518) | U.S. Public Health Service | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | Medical College of Wisconsin | TerumoBCT | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U10HL069294) | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Milliman | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Doris M. Ponce, Mary Eapen, Rodney Sparapani, Tracey A. O'Brien, Ka Wah Chan, Junfang Chen, John Craddock, Kirk R. Schultz, John E. Wagner, Miguel-Angel Perales, Juliet N. Barker

Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research

Journal Article published Dec 2015 in Biology of Blood and Marrow Transplantation volume 21 issue 12 on pages 2154 to 2159

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (U24-CA076518, HHSH250201200016) | U.S. Public Health Service | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | TerumoBCT | Soligenix, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | National Institute of Allergy and Infectious Diseases | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute (5U10HL069294) | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | HistoGenetics | Genentech | Genzyme | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration | Celgene | Leukemia and Lymphoma Society of Canada | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | Milliman | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Michael J. Burke, Michael R. Verneris, Jennifer Le Rademacher, Wensheng He, Hisham Abdel-Azim, Allistair A. Abraham, Jeffery J. Auletta, Mouhab Ayas, Valerie I. Brown, Mitchell S. Cairo, Ka Wah Chan, Miguel A. Diaz Perez, Christopher C. Dvorak, R. Maarten Egeler, Lamis Eldjerou, Haydar Frangoul, Gregory M.T. Guilcher, Robert J. Hayashi, Ahmed Ibrahim, Kimberly A. Kasow, Wing H. Leung, Richard F. Olsson, Michael A. Pulsipher, Niketa Shah, Nirali N. Shah, Elizabeth Thiel, Julie-An Talano, Carrie L. Kitko

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia

Journal Article published May 2017 in Biology of Blood and Marrow Transplantation volume 23 issue 5 on pages 767 to 775

Research funded by U.S. Public Health Service (5U24-CA076518) | National Cancer Institute (HHSH250201200016C) | National Heart, Lung, and Blood Institute | National Institute of Allergy and Infectious Diseases (5U10HL069294) | Office of Naval Research (N00014-15-1-0848, N00014-16-1-2020) | Actinium Pharmaceuticals | Alexion Pharmaceuticals | Amgen

Authors: Hien Duong Liu, Kwang Woo Ahn, Zhen-Huan Hu, Mehdi Hamadani, Taiga Nishihori, Baldeep Wirk, Amer Beitinjaneh, David Rizzieri, Michael R. Grunwald, Mitchell Sabloff, Richard F. Olsson, Ashish Bajel, Christopher Bredeson, Andrew Daly, Yoshihiro Inamoto, Navneet Majhail, Ayman Saad, Vikas Gupta, Aaron Gerds, Adriana Malone, Martin Tallman, Ran Reshef, David I. Marks, Edward Copelan, Usama Gergis, Mary Lynn Savoie, Celalettin Ustun, Mark R. Litzow, Jean-Yves Cahn, Tamila Kindwall-Keller, Gorgun Akpek, Bipin N. Savani, Mahmoud Aljurf, Jacob M. Rowe, Peter H. Wiernik, Jack W. Hsu, Jorge Cortes, Matt Kalaycio, Richard Maziarz, Ronald Sobecks, Uday Popat, Edwin Alyea, Wael Saber

Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation

Journal Article published 15 Mar 2016 in British Journal of Haematology volume 174 issue 2 on pages 235 to 248

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute (U24-CA076518) | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | TerumoBCT | Leukemia and Lymphoma Society | Soligenix, Inc. | Milliman USA, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | National Institute of Allergy and Infectious Diseases (5U10HL069294) | Sanofi US | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | Genentech | Genzyme | Miltenyi Biotec, Inc. | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Tarix Pharmaceuticals | Amgen | HistoGenetics, Inc. | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Timothy S. Fenske, Kwang W. Ahn, Tara M. Graff, Alyssa DiGilio, Qaiser Bashir, Rammurti T. Kamble, Ernesto Ayala, Ulrike Bacher, Jonathan E. Brammer, Mitchell Cairo, Andy Chen, Yi-Bin Chen, Saurabh Chhabra, Anita D'Souza, Umar Farooq, Cesar Freytes, Siddhartha Ganguly, Mark Hertzberg, David Inwards, Samantha Jaglowski, Mohamed A. Kharfan-Dabaja, Hillard M. Lazarus, Sunita Nathan, Attaphol Pawarode, Miguel-Angel Perales, Nishitha Reddy, Sachiko Seo, Anna Sureda, Sonali M. Smith, Mehdi Hamadani

Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis

Journal Article published Jun 2018 in Biology of Blood and Marrow Transplantation volume 24 issue 6 on pages 1163 to 1171

Research funded by Medac GmbH | National Marrow Donor Program | Kiadis Pharma | National Cancer Institute | Roswell Park Cancer Institute | Sigma-Tau Pharmaceuticals | StemCyte | Medical College of Wisconsin | TerumoBCT | Leukemia and Lymphoma Society | Soligenix, Inc. | Milliman USA, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | National Institute of Allergy and Infectious Diseases (5U10HL069294, HHSH250201200016C) | Sanofi US | Ariad Pharmaceuticals | University of Utah | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | National Heart, Lung, and Blood Institute | Miltenyi Biotec | Millennium: The Takeda Oncology Co. | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | Genentech | Genzyme | Teva Neuroscience, Inc. | Public Health Service (U24-CA076518) | Stemsoft Software, Inc. | Health Research | Otsuka America Pharmaceutical | Health Resources and Services Administration (N00014-13-1-0039, N00014-14-1-0028)) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | HistoGenetics, Inc. | Office of Naval Research | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Karyopharm Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Carla Casulo, Jonathan W. Friedberg, Kwang W. Ahn, Christopher Flowers, Alyssa DiGilio, Sonali M. Smith, Sairah Ahmed, David Inwards, Mahmoud Aljurf, Andy I. Chen, Hannah Choe, Jonathon Cohen, Edward Copelan, Umar Farooq, Timothy S. Fenske, Cesar Freytes, Sameh Gaballa, Siddhartha Ganguly, Yogesh Jethava, Rammurti T. Kamble, Vaishalee P. Kenkre, Hillard Lazarus, Aleksandr Lazaryan, Richard F. Olsson, Andrew R. Rezvani, David Rizzieri, Sachiko Seo, Gunjan L. Shah, Nina Shah, Melham Solh, Anna Sureda, Basem William, Aaron Cumpston, Andrew D. Zelenetz, Brian K. Link, Mehdi Hamadani

Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR)

Journal Article published 12 Oct 2018 in Cancer volume 125 issue 1 on pages 144 to 152

Research funded by Novartis Pharmaceuticals Corporation | National Cancer Institute (4U10HL069294, 5U24CA076518) | Patient-Centered Outcomes Research Institute | Anonymous donation to the Medical College of Wisconsin | Medical College of Wisconsin | Pfizer | Actinium Pharmaceuticals | Fred Hutchinson Cancer Research Center | Seattle Genetics | National Institute of Allergy and Infectious Diseases (5U24CA076518) | Immucor | Janssen Scientific Affairs, LLC | Millennium | Bristol Myers Squibb Oncology | Amneal Biosciences | Kite Pharma, Inc. | Gamida Cell Ltd. | University of Minnesota | National Heart, Lung, and Blood Institute (4U10HL069294, 5U24CA076518) | Swedish Orphan Biovitrum, Inc. | Miltenyi Biotec | MesoScale Diagnostics, Inc. | HistoGenetics | Spectrum Pharmaceuticals | Atara Biotherapeutics, Inc. | Mesoblast | Medac, GmbH | Telomere Diagnostics, Inc. | Shire | Sunesis Pharmaceuticals, Inc. | Mediware | Jazz Pharmaceuticals | Gilead Sciences | Neovii Biotech NA, Inc. | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | MedImmune | Be The Match Foundation | Amgen | bluebird bio, Inc. | Office of Naval Research (N00014-17-1-2388, N0014-17-1-2850) | Astellas Pharma US | Angiocrine Bioscience, Inc. | Incyte Corporation | Karyopharm Therapeutics | Otsuka Pharmaceutical | Juno Therapeutics

Authors: Neel S. Bhatt, Ruta Brazauskas, Heather R. Tecca, Jeanette Carreras, Linda J. Burns, Rachel Phelan, Rachel B. Salit, Karen L. Syrjala, Julie-An M. Talano, Bronwen E. Shaw

Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma

Journal Article published Jan 2017 in Biology of Blood and Marrow Transplantation volume 23 issue 1 on pages 60 to 66

Research funded by Medac GmbH | Kiadis Pharma | Takeda Oncology | Sigma-Tau Pharmaceuticals | StemCyte | TerumoBCT | Leukemia and Lymphoma Society | Soligenix, Inc. | Milliman USA, Inc. | Actinium Pharmaceuticals | Therakos | Fred Hutchinson Cancer Research Center | Gentium SpA | WellPoint | Gamida Cell Teva Joint Venture Ltd. | Seattle Genetics | Sanofi | Ariad Pharmaceuticals | University of Utah | NHLBI and NCI (5U10HL069294) | Health Research, Inc. Roswell Park Cancer Institute | University of Minnesota | Perkin Elmer, Inc. | Onyx Pharmaceuticals | Blue Cross and Blue Shield Association | Osiris Therapeutics | Optum Healthcare Solutions, Inc. | Genentech | Genzyme | Miltenyi Biotec, Inc. | Teva Neuroscience, Inc. | Stemsoft Software, Inc. | National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID) (U24-CA076518) | The Medical College of Wisconsin | Otsuka America Pharmaceutical | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | St. Baldrick's Foundation | Swedish Orphan Biovitrum | Be The Match Foundation | Tarix Pharmaceuticals | Amgen | HistoGenetics, Inc. | Office of Naval Research (N00014-13-1-0039, N00014-14-1-0028) | Chimerix, Inc. | Jeff Gordon Children's Foundation | Incyte Corporation | Allos Therapeutics | GlaxoSmithKline | Fresenius-Biotech North America, Inc. | Remedy Informatics

Authors: Robert F. Cornell, Veronika Bachanova, Anita D'Souza, Kwang Woo-Ahn, Michael Martens, Jiaxing Huang, A. Samer Al-Homsi, Saurabh Chhabra, Edward Copelan, Miguel-Angel Diaz, Cesar O. Freytes, Robert Peter Gale, Siddhartha Ganguly, Mehdi Hamadani, Gerhard Hildebrandt, Rammurti T. Kamble, Mohamed Kharfan-Dabaja, Tamila Kindwall-Keller, Hillard M. Lazarus, David I. Marks, Taiga Nishihori, Richard F. Olsson, Ayman Saad, Saad Usmani, David H. Vesole, Jean Yared, Tomer Mark, Yago Nieto, Parameswaran Hari

Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis

Journal Article published Apr 2018 in Biology of Blood and Marrow Transplantation volume 24 issue 4 on pages 827 to 831

Research funded by National Cancer Institute | Patient-Centered Outcomes Research Institute | Anonymous donation to the Medical College of Wisconsin | Takeda Oncology | Medical College of Wisconsin | Millennium, the Takeda Oncology Co. | Actinium Pharmaceuticals | Cerus Corporation | Spectrum Pharmaceuticals, Inc. | Pfizer, Inc | Fred Hutchinson Cancer Research Center | Pharmacyclics, LLC | PIRCHE AG | Seattle Genetics | National Institute of Allergy and Infectious Diseases | Immucor | Janssen Scientific Affairs, LLC | Bristol Myers Squibb Oncology | Amneal Biosciences | Kite Pharma, Inc. | Gamida Cell Ltd. | University of Minnesota | National Heart, Lung, and Blood Institute | Swedish Orphan Biovitrum, Inc. | MesoScale Diagnostics, Inc. | Juno Therapeutics; Karyopharm Therapeutics, Inc. | National Marrow Donor Program; | Atara Biotherapeutics, Inc. | Mesoblast | Medac, GmbH | Miltenyi Biotec, Inc. | Telomere Diagnostics, Inc. | Shire | Sunesis Pharmaceuticals, Inc. | Jazz Pharmaceuticals | Gilead Sciences | Neovii Biotech NA, Inc. | Health Resources and Services Administration (HHSH250201200016C) | Celgene | Merck | MedImmune | St. Baldrick's Foundation | Be The Match Foundation | Sanofi Genzyme | Amgen | HistoGenetics, Inc. | bluebird bio, Inc. | Office of Naval Research (N00014-17-1-2388, N00014-16-1-2020)) | Chimerix, Inc. | Astellas Pharma US | Angiocrine Bioscience, Inc. | Incyte Corporation | Novartis Pharmaceuticals Corporation; Otsuka Pharmaceutical Co, Ltd. – Japan

Authors: Basem M. William, Tao Wang, Michael D. Haagenson, Katharina Fleischhauer, Michael Verneris, Katharine C. Hsu, Marcos J. de Lima, Marcelo Fernandez-Viña, Stephen R. Spellman, Stephanie J. Lee, Brian T. Hill